Boehringer Ingelheim Launches New Arabic Website to Support Patients Living with Idiopathic
Boehringer Ingelheim Launches New Arabic Website to Support Patients Living with Idiopathic Pulmonary Fibrosis in the Region
Search
Idiopathic Pulmonary Fibrosis treatment launched in Egypt
Idiopathic Pulmonary Fibrosis treatment launched in Egypt
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
In 2023, Boehringer Ingelheim in India, Middle East, Turkey and Africa (IMETA) region achieved net sales of EUR 779 million, reflecting a 13% increase compared to the previous year.
Meet our Team
Meet our Team
World Stroke Organization Honors Eight Stroke Centers powered by Angels Award for their Efforts in developing stroke management in Egypt
World Stroke Organization Honors Eight Stroke Centers powered by Angels Award
History video
Learn more about the history of the innovative pharmaceutical company Boehringer Ingelheim
CENTRAGARD internal parasite protection for cats in US
Centragard, an innovative product to treat heartworm disease in cats, launched in the U.S.
History
Learn more about the history of the innovative pharmaceutical company Boehringer Ingelheim.
Cairo Tower lights up in Blue for World Diabetes Day
Cairo Tower lights up in Blue for World Diabetes Day
International Women's Day
We celebrate International Women’s Day with this year’s UN Women motto being “Gender Equality Today for a Sustainable Tomorrow”
Leading experts shed light on importance of establishing dedicated stroke management centers
Leading experts shed light on importance of establishing dedicated stroke management centers across healthcare facilities
Production Insights
Boehringer Ingelheim makes an important contribution to the reliable and sustainable supply of pharmaceuticals
Therapeutics
Therapeutics
BI Access to Healthcare Strategy_Availability
Boehringer Ingelheim aspires to be a leader in ensuring improved access by delivering More Health to humans, animals and communities around the world. Read more about our holistic approach, based on partnerships and local empowerment.
Equestrian sports horse health awareness Alex Hua Tian
Together with Olympian trailblazer and eventer Alex Hua Tian, we educate about equine health in China.
Advances in vectored vaccines for poultry
Vaccine design technologies have made huge advances in recent years. One of the newer categories of vaccine, vectored vaccines, is overcoming challenges that conventional vaccines do not meet.
Cattle well-being at farms’ core
From pain management to responsible use of antibiotics, Cattle First introduces a whole cow approach to look after health and productivity.
Resizing our Carbon Footprint
The ecological balance of the world is at a tipping point.
Empowering all employees
Boehringer Ingelheim has been awarded as a Global Top Employer for the second year in succession
Science Focus
Science Focus
Metabolic Diseases
Metabolic Diseases
The UAE MOHAP Approves the First and Only Therapy for the Treatment of Adult Generalized Pustular Psoriasis Flares
The first treatment of its kind in the UAE by Boehringer Ingelheim is the only FDA and EMA-approved medication used to treat GPP flares in adult patients and works to help block a source of inflammation that may cause GPP flares
Skin Diseases
Skin Diseases
Boehringer Ingelheim Academy
Find out more about our networking and educational initiative
NeO - smart and sustainable vaccines
The reduction in the environmental impact of the new NeO vaccine packaging illustrates Boehringer Ingelheim’s drive for environmental responsibility.